Showing results (151-160 of 6,879) with videos related to

Sort By:
Pageof 688
Leukemia Research|December 3, 2023
Evaluation of palonosetron, fosaprepitant, and olanzapine as antiemetic prophylaxis for fludarabine and melphalan-based conditioning regimens prior to allogeneic hematopoietic stem cell transplantsRiley Karpen, Jeremy Sen, Sarah Wall, et al.
Leukemia Research|November 28, 2023
The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspectiveCarlo Pescia, Gianluca Lopez, Daniele Cattaneo, et al.
Leukemia Research|September 10, 2023
MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patientsGunnar Larfors, Daniel Moreno Berggren, Hege Garelius, et al.
Leukemia Research|August 10, 2023
Economic burden during remission and after relapse among older patients with newly diagnosed acute myeloid leukemia without hematopoietic stem cell transplant: A retrospective study using the SEER-Medicare databaseAndrew M Brunner, David Huggar, Ronda Copher, et al.
Leukemia Research|August 26, 2023
Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 studyFernando De la Garza-Salazar, Perla Rocío Colunga-Pedraza, David Gómez-Almaguer, et al.
Leukemia Research|August 18, 2023
Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective studyShinichi Kako, Shun-Ichi Kimura, Hidenori Wada, et al.
Leukemia Research|August 20, 2023
Safety and efficacy of FLAG-Ida-based therapy combined with venetoclax for the treatment for newly diagnosed and relapsed/refractory patients with AML - A systematic reviewA Sherban, D Fredman, S Shimony, et al.
Leukemia Research|October 16, 2023
A new prognostic risk model for acute myeloid leukemia patients based on telomere-related genesFan Zhang, Hongmin Du, Chenxi Hu, et al.
Leukemia Research|October 6, 2023
Integrating electronic geriatric assessment and frailty screening for adults with acute myeloid leukemia to drive personalized treatment decisionsOmer Hassan Jamy, Margaret Kasner, Sarah Wall, et al.
Leukemia Research|September 30, 2023
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromesTamanna Haque, Felix López Cadenas, Blanca Xicoy, et al.
Pageof 688